Short Interest in Talphera, Inc. (NASDAQ:TLPH) Rises By 42.7%

Talphera, Inc. (NASDAQ:TLPH) saw a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 59,800 shares, an increase of 42.7% from the November 30th total of 41,900 shares. Approximately 0.4% of the shares of the company are sold short. Based on an average trading volume of 99,000 shares, the days-to-cover ratio is currently 0.6 days.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Nantahala Capital Management LLC acquired a new position in Talphera during the second quarter valued at approximately $1,773,000. Rosalind Advisors Inc. acquired a new position in shares of Talphera during the 3rd quarter worth $650,000. Finally, Turtle Creek Wealth Advisors LLC bought a new stake in shares of Talphera during the 2nd quarter worth $64,000. Institutional investors own 37.67% of the company’s stock.

Talphera Price Performance

NASDAQ:TLPH traded up $0.03 during trading hours on Friday, reaching $0.53. 163,105 shares of the company were exchanged, compared to its average volume of 92,952. The company has a market capitalization of $9.03 million, a P/E ratio of -0.77 and a beta of 0.25. The business has a 50 day moving average of $0.77 and a 200 day moving average of $0.86. Talphera has a 1-year low of $0.50 and a 1-year high of $1.61.

Analyst Upgrades and Downgrades

Separately, Maxim Group raised shares of Talphera to a “strong-buy” rating in a research report on Friday, November 8th.

About Talphera

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit.